Status:
COMPLETED
Purpose of This Study is to Evaluate the Safety and Efficacy of One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects
Lead Sponsor:
Glaukos Corporation
Conditions:
Primary Open Angle Glaucoma (POAG)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of the iStent medical device that is implanted into the eye and designed to reduce eye pressure in patients with your condition.
Eligibility Criteria
Inclusion
- Diagnosed with primary open-angle glaucoma (POAG)
- Subject on two topical hypotensive medications
Exclusion
- Traumatic, uveitic, neovascular, or angle closure glaucoma
- Fellow eye already enrolled
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2019
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT01252849
Start Date
December 1 2010
End Date
October 8 2019
Last Update
August 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
S.V. Malayan's Ophthalmology Centre
Yerevan, Armenia, 375108